Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm and TerrAscend Sign Cannabis Extraction Agreement

Stockhouse Editorial January 9, 2019

MediPharm Labs Announces Increased Management Shareholdings and Stock Option Grant

GlobeNewswire January 9, 2019

MediPharm Labs Signs Large Multi-Year Cannabis Extraction Agreement With TerrAscend Marking Strong Start to 2019

GlobeNewswire January 8, 2019

Canadian Cannabis Awards Winner Commences Trading in the US

Stockhouse Editorial January 7, 2019

MediPharm Labs Commences Trading in United States on OTCQB Market Under Symbol MLCPF

GlobeNewswire January 7, 2019

MediPharm Labs Announces Addition to Horizons Marijuana Life Sciences Index ETF

GlobeNewswire December 28, 2018

MediPharm Labs Increases Annual Production Capacity by 50% Up to 150,000KG; Positioned to Meet Significant Demand for Purified Cannabis Concentrates and Oil

GlobeNewswire December 24, 2018

Cannabis Extraction Deal With Canopy Growth Announced by MediPharm

Stockhouse Editorial December 12, 2018

Assessing MediPharm Labs' Sales Agreement with Canopy Growth -- CFN Media

GlobeNewswire December 12, 2018

MediPharm Awarded Canadian Cannabis Start-Up of the Year

Stockhouse Editorial December 5, 2018

MediPharm Labs Wins Canadian Cannabis Start-Up of the Year

GlobeNewswire December 4, 2018

IIROC Trading Resumption - LABS

Canada NewsWire November 29, 2018

Canopy Growth Completes Strategic Extract Supply Agreement With MediPharm Labs

Canada NewsWire November 29, 2018

IIROC Trading Halt - LABS

Canada NewsWire November 29, 2018

MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program

GlobeNewswire November 14, 2018

New Green Frontier 2018; Gravitas Financial Inc.’s inaugural cannabis investor conference announces Gene Simmons as keynote speaker

GlobeNewswire November 13, 2018

IIROC Trading Resumption - LABS

Canada NewsWire November 12, 2018

MediPharm Labs Corp. Receives Sales Licence from Health Canada

GlobeNewswire November 12, 2018

IIROC Trading Halt - LABS

Canada NewsWire November 12, 2018

View from the C-Suite: Pat McCutcheon, President and CEO, MediPharm Labs Corp., tells his company's story. Filmed on October 5, 2018

Canada NewsWire November 9, 2018